Proceedings of the International symposium on Sustainable Drug Design and Nanoparticle development: Quantum and Computational Perspectives (SDDNDQCP 2025)

<Previous Article In Volume
Next Article In Volume>

A Prospective Study of Assessment On Cost of Illness and Its Impact on Quality of Life in Dialysis Patients

Authors
R. Narasimha Naik1, *, M. Sahithi2, Sk. Roshanara2, Md. Musharaf2, S. Amrutha2, B. Manasa2
1Department of Pharmacology, Dattakala Institute of Pharmaceutical Sciences and Research (For Girls), Swami Chincholi, Bhigwan, Pune, Maharashtra, India
2Department of Pharmacology and Pharmacy Practice, Nirmala College of Pharmacy, AtmakurMangalagiri, Guntur, Andhra Pradesh, India
*Corresponding author. Email: narasimhamp09@gmail.com
Corresponding Author
R. Narasimha Naik
Available Online 13 August 2025.
DOI
10.2991/978-94-6463-813-4_13How to use a DOI?
Keywords
Chronic kidney disease; dialysis; health related quality of life (HRQOL); kidney disease quality of life (KDQOL); treatment burden; Hypertension & Diabetes Mellitus
Abstract

Chronic kidney disease (CKD) is defined as kidney damage or a glomerular filtration rate (GFR) of less than 60 ml/min/1.73 m2 for three months or longer. An artificial method for eliminating waste and extra water from the body is dialysis., is the only option for preserving renal function and patient health in advanced CKD. HRQOL, a subjective measure of how a disease and its treatment plan affect patients, is assessed using TBQ and KDQOL questionnaires. The study aim was to assess the QOL associated with health and the cost of disease in dialysis patients. HRQOL among dialysis patients is assessed by using TBQ and KDQOL-36 questionnaires. Objectives are to evaluate HRQOL among CKD patients receiving dialysis by using KDQOL-36 questionnaire. And to assess the cost of illness and its impact on QOL in dialysis patients using a treatment burden questionnaire. A prospective study was conducted including 150 dialysis patients which showed males at the age group of 56–65 years are more prone to CKD. Student T-test and ANOVA test for statistical analysis and Pearson correlation is used to assess correlation between treatment burden and HRQOL. Since chronic kidney disease (CKD) is a prominent cause of morbidity and mortality among patients, the assessment of health-related quality of life (HRQOL) is vital for improving their therapeutic results. QOL of dialysis patients can be improved by treating complications. Medication and financial burden are most observed in dialysis patients.

Copyright
© 2025 The Author(s)
Open Access
Open Access This chapter is licensed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which permits any noncommercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license and indicate if changes were made.

Download article (PDF)

<Previous Article In Volume
Next Article In Volume>
Volume Title
Proceedings of the International symposium on Sustainable Drug Design and Nanoparticle development: Quantum and Computational Perspectives (SDDNDQCP 2025)
Series
Advances in Health Sciences Research
Publication Date
13 August 2025
ISBN
978-94-6463-813-4
ISSN
2468-5739
DOI
10.2991/978-94-6463-813-4_13How to use a DOI?
Copyright
© 2025 The Author(s)
Open Access
Open Access This chapter is licensed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which permits any noncommercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license and indicate if changes were made.

Cite this article

risenwbib
TY  - CONF
AU  - R. Narasimha Naik
AU  - M. Sahithi
AU  - Sk. Roshanara
AU  - Md. Musharaf
AU  - S. Amrutha
AU  - B. Manasa
PY  - 2025
DA  - 2025/08/13
TI  - A Prospective Study of Assessment On Cost of Illness and Its Impact on Quality of Life in Dialysis Patients
BT  - Proceedings of the International symposium on Sustainable Drug Design and Nanoparticle development: Quantum and Computational Perspectives (SDDNDQCP 2025)
PB  - Atlantis Press
SP  - 178
EP  - 190
SN  - 2468-5739
UR  - https://doi.org/10.2991/978-94-6463-813-4_13
DO  - 10.2991/978-94-6463-813-4_13
ID  - Naik2025
ER  -